Immunosenescence: role and measurement in influenza vaccine response among the elderly.
Immunosenescence refers to the inability of an aging immune system to produce an appropriate and effective response to challenge. This immune dysfunction may manifest as increased susceptibility to infection, cancer, autoimmune disease, and vaccine failure. Mounting biological evidence supports the potential clinical relevance and impact of immunosenenscence. We briefly review immunosenescence with a focus on replicative senescence in cytotoxic T cells and recent clinical studies examining its association with influenza and infectious disease outcomes.
Targonski
Paul V
PV
Vaccine Research Group, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905-0001, United States. targonski.paul@mayo.edu
Jacobson
Robert M
RM
Poland
Gregory A
GA
D000375:Aging / Q000276:immunology*; D000914:Antibodies, Viral / Q000096:biosynthesis; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007107:Immune System / Q000502:physiology; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000276:immunology; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology / Q000502:physiology*; D014611:Vaccination; D022223:Vaccines, Subunit / Q000008:administration & dosage / Q000276:immunology
D000914:Antibodies, Viral; D007252:Influenza Vaccines; D022223:Vaccines, Subunit